Literature DB >> 24402574

Expression profile of apoptosis-related genes potentially explains early recurrence after definitive chemoradiation in esophageal squamous cell carcinoma.

Yongshun Chen1, Ying Wang, Haixia Song, Jin Wang, Haijun Yang, Yubing Xia, Jianxin Xue, Shidong Li, Ming Chen, You Lu.   

Abstract

Definitive chemoradiation is a curative treatment option for patients with locoregional esophageal squamous cell carcinoma (ESCC) who are not suitable for surgical resection, but many tend to develop local recurrence. The purpose of the study was to investigate factors affecting local recurrence of the tumor. Seventy-two patients with stage II-III thoracic ESCC who received definitive concurrent chemoradiation (CRT) and completely responded to the treatment were enrolled into this study. The case patients were 49 patients who recurred locally within 24 months after definitive CRT and 23 patients who did not have a local recurrence within 24 months were considered as controls. We investigated whether dysregulation of apoptosis-related genes was associated with early tumor recurrence. Quantitative real-time polymerase chain reaction showed upregulation of BCLAF1 and downregulation of BAG4, CARD6, IGF1R, and TNF in the tissues of case patients, as compared with controls. Among the patients with recurrent ESCC, those with tumors which exhibited more than twofold upregulated BCLAF1 and more than twofold downregulated BAG4 and TNF had a decreased time interval to local recurrence. Three gene pairs of the downregulated genes showed a significant correlation with local recurrence: BAG4 and CARD6, BAG4 and TNF, CARD6, and TNF. The patients with T3-4 disease and those with tumor >3 cm in length had a trend toward early local recurrence, though the associations were not reached statistical significance. Upregulation of BCLAF1 and downregulation of BAG4 and TNF was independently associated with early local recurrence in multivariate analysis (P < 0.05). This study supports the involvement of apoptosis-related genes in early tumor recurrence after definitive chemoradiation in patients with stage II-III thoracic ESCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24402574     DOI: 10.1007/s13277-013-1569-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Authors:  Michael Stahl; Martin Stuschke; Nils Lehmann; Hans-Joachim Meyer; Martin K Walz; Siegfried Seeber; Bodo Klump; Wilfried Budach; Reinhard Teichmann; Marcus Schmitt; Gerd Schmitt; Claus Franke; Hansjochen Wilke
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

3.  Enhanced expression of Silencer of death domains (SODD/BAG-4) in pancreatic cancer.

Authors:  F Ozawa; H Friess; A Zimmermann; J Kleeff; M W Büchler
Journal:  Biochem Biophys Res Commun       Date:  2000-05-10       Impact factor: 3.575

Review 4.  Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.

Authors:  Peter E Clayton; Indraneel Banerjee; Philip G Murray; Andrew G Renehan
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

Review 5.  Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment.

Authors:  Salvador Rodriguez-Nieto; Boris Zhivotovsky
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 6.  TNF and cancer: the two sides of the coin.

Authors:  Simone Mocellin; Donato Nitti
Journal:  Front Biosci       Date:  2008-01-01

Review 7.  Apoptotic pathways in tumor progression and therapy.

Authors:  Armelle Melet; Keli Song; Octavian Bucur; Zainab Jagani; Alexandra R Grassian; Roya Khosravi-Far
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

8.  Failure patterns in patients with esophageal cancer treated with definitive chemoradiation.

Authors:  James Welsh; Stephen H Settle; Arya Amini; Lianchun Xiao; Akihiro Suzuki; Yuki Hayashi; Wayne Hofstetter; Ritsuko Komaki; Zhongxing Liao; Jaffer A Ajani
Journal:  Cancer       Date:  2011-10-05       Impact factor: 6.860

Review 9.  In search of a function for BCLAF1.

Authors:  Haya Sarras; Solmaz Alizadeh Azami; J Peter McPherson
Journal:  ScientificWorldJournal       Date:  2010-07-20

10.  Targeting TNF-alpha for cancer therapy.

Authors:  Elizabeth R Burton; Steven K Libutti
Journal:  J Biol       Date:  2009-10-23
View more
  4 in total

Review 1.  Clinical tools to predict outcomes in patients with esophageal cancer treated with definitive chemoradiation: are we there yet?

Authors:  Abraham J Wu; Karyn A Goodman
Journal:  J Gastrointest Oncol       Date:  2015-02

2.  PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells.

Authors:  Gui-Ling Fan; Yong Yao; Li Yao; Yun Li
Journal:  Oncol Lett       Date:  2014-10-29       Impact factor: 2.967

3.  Bcl‑2 associated athanogene 4 promotes proliferation, migration and invasion of gastric cancer cells.

Authors:  Lizhi Yi; Zhenbing Lv; Jianmei Wang; Xianfei Zhong
Journal:  Mol Med Rep       Date:  2017-07-21       Impact factor: 2.952

4.  Bioinformatics analysis of dysregulated microRNAs in the nipple discharge of patients with breast cancer.

Authors:  Kai Zhang; Ya-Wen Wang; Rong Ma
Journal:  Oncol Lett       Date:  2017-03-03       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.